AET

Aetna

NYSE

Add Alert

AET

Aetna

NYSE

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Sanibel Island Free

04/03/23 6:17 PM

Post #18

Millions about to loose Medicaid coverage as pandemic restrictions are lifted , google it for your due deligence will show up in 2nd quarter numbers , most coverage is with people of color and Hispanic.

Enterprising Investor PremiumMember

11/26/18 10:00 AM

Post #17

Re: #16: @Enterprising Investor - The Aetna/CVS deal is in the final stages.

CVS Health Corporation and Aetna Inc. received the final regulatory approval required for CVS Health to complete its acquisition of Aetna (11/26/18)

The closing of the acquisition of Aetna is expected to occur on or about 11/28/18, subject to the satisfaction of all other closing conditions.

Enterprising Investor PremiumMember

11/23/18 3:17 PM

Post #16

The Aetna/CVS deal is in the final stages.

In connection with the closing of the proposed acquisition of Aetna Inc., all of the required change in control filings were submitted to 28 state insurance departments in January 2018. CVS Health Corporation has received approval from 26 of the 28 state departments of insurance. CVS Health has made significant progress and is in the final stages of the approval process with the remaining two states. CVS Health is confident that these remaining approvals will be secured. As a result, the Acquisition is now expected to close after the Thanksgiving holiday.

https://www.sec.gov/Archives/edgar/data/64803/000119312518330651/d658002d8k.htm

AET shareholders will receive $145 in cash and .8378 shares of CVS per share.

13moonster Free

02/20/18 1:35 PM

Post #15

Why does AET trade at $178, when there is an offer of $207 on the table?

Lowjack

02/12/18 3:55 PM

Post #14

Re: #13: @jones99 - Great deal for CVS acquiring AET. They are

Get wrecked MFk'rs!

http://fox40.com/2018/02/11/california-launches-investigation-following-stunning-admission-by-aetna-medical-director/

jones99

12/04/17 6:10 AM

Post #13

Great deal for CVS acquiring AET. They are buying not only an Insurance giant but the oldest player who knows what they are doing!

x1power

08/17/16 10:27 AM

Post #12

Re: #11: @x1power - Apparently, the solution to our health care problems

Typing error in previous post, meant high-risk . . . not high-rise (however rural health care costs are high-rise in that they cannot easily be served by conventional same-old-same-old methods).

x1power

08/17/16 10:21 AM

Post #11

Re: #10: @venturecapp - Aetna Beats By $0.15, Reports Revenues In-Line

Apparently, the solution to our health care problems as a nation is to continue to let them grow at a faster rate than energy and food costs. At this rate of 'profit inflation', there will be no way to politically cut the deficit, repair the infrastructure, and reduce federal and state spending without cutting our military and international spending to the bone?

Or, we could turn our health care system over to the like of BA and LMT and see what steps they can think up with MSFT and Google, to try and cut the red tape in health care.

Why not place high expense/high risk low income medical program users in a separate non-profit medical care program , and actually pay them to take the steps to become as healthy as they can under their present medical treatment regimes?

You cannot tell me that a mobile vehicle centered rural program using outfitted buses as dental, vision, and pharmacy and basic health care treatment . . . could not help dramatically to reach, treat, and monitor with modern wireless user Bluetooth readout personal devices high-rise, low-income patients and school populations. Exactly what are we spending our healthcare $$s on?

Government can further help by spending medical school students under supervision and military medical units, along on these bus trips to both gain knowledge and to serve the unmet national and state health needs of our people. Oh . . . wait . . . the AMA
would demand/need a cut on ever patient care plan they have purposefully 'neglected' to serve. Guess that could not happen.

venturecapp Free

02/01/16 3:16 PM

Post #10

Aetna Beats By $0.15, Reports Revenues In-Line

http://marketexclusivecom/aetna-aet-beats-by-0-15-reports-revenues-in-line/2196/

Penny Roger$ Free

01/19/15 10:20 AM

Post #9

Re: #1: @ICEQUITY - Aetna (AET)

$AET ~ One of ONLY a few Health Care providers that are Publicly Traded.

Penny Roger$ Free

04/26/12 5:00 AM

Post #8

Penny Roger$ Free

02/02/12 4:39 AM

Post #7

~ $AET ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $AET ~ Earnings expected on Wednesday *
This Week In Earnings: Earnings are coming or are already posted! This is what the charts look like! If you play the earnings these posts can be very helpful to you!
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.

http://stockcharts.com/h-sc/ui?s=AET&p=D&b=3&g=0&id=p88783918276&a=237480049

http://stockcharts.com/h-sc/ui?s=AET&p=W&b=3&g=0&id=p54550695994

~ Barchart: http://barchart.com/quotes/stocks/AET?
~ OTC Markets: http://www.otcmarkets.com/stock/AET/company-info
~ Google Finance: http://www.google.com/finance?q=AET
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=AET#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=AET+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=AET
Finviz: http://finviz.com/quote.ashx?t=AET
~ BusyStock: http://busystock.com/i.php?s=AET&v=2
~ CandlestickChart: http://www.candlestickchart.com/cgi/chart.cgi?symbol=AET&exchange=US
~ Investorshub Trades: http://ih.advfn.com/p.php?pid=trades&symbol=AET
~ Investorshub Board Search: http://investorshub.advfn.com/boards/getboards.aspx?searchstr=AET
~ Investorshub PostStream Search: http://investorshub.advfn.com/boards/poststream.aspx?ticker=AET
~ Investorshub Goodies Search: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18582&srchyr=2011&SearchStr=AET
~ Investorshub Message Search: http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=AET
~ MarketWatch: http://www.marketwatch.com/investing/stock/AET/profile
~ E-Zone Chart: http://www.windchart.com/ezone/signals/?symbol=AET
~ 5-Min Wind: http://www.windchart.com/stockta/analysis?symbol=AET
~ 10-Min Wind: http://www.windchart.com/stockta/analysis?symbol=AET&size=l&frequency=10&color=g
~ 30-Min Wind: http://www.windchart.com/stockta/analysis?symbol=AET&size=l&frequency=30&color=g
~ 60-Min Wind: http://www.windchart.com/stockta/analysis?symbol=AET&size=l&frequency=60&color=g

http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

EZ2

01/19/12 7:08 AM

Post #6

Poop.....sure missed this one! frown

ICEQUITY

01/27/11 4:17 PM

Post #5

Re: #4: @ICEQUITY - VIPPS approved Aetna Rx Home Delivery (AET)

Zacks Analyst Blog Highlights: WellPoint, Express Scripts, Unitedhealth Group, CIGNA Corporation and Aetna- Zack did you say $AET is on your @Demandmedia Rx @Legitscripts List?

http://bit.ly/EQUITIESRxVIPPSINDEX
http://bit.ly/EQUITIESDAMAN
http://bit.ly/EQUITIES

Date : 01/27/2011 @ 10:08AM
Source : PR Newswire
Stock : Aetna (AET)
Quote : 34.12 0.64 (1.91%) @ 3:41PM

Zacks Analyst Blog Highlights: WellPoint, Express Scripts, Unitedhealth Group, CIGNA Corporation and Aetna
Aetna (NYSE:AET)
Intraday Stock Chart
Today : Thursday 27 January 2011

Zacks.com Analyst Blog features: WellPoint Inc. (NYSE: WLP), Express Scripts (Nasdaq: ESRX), Unitedhealth Group, Inc. (NYSE: UNH), CIGNA Corporation (NYSE: CI) and Aetna Inc. (NYSE: AET).

(Logo: photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579

Here are highlights from Wednesday's Analyst Blog:

WellPoint Exceeds Expectations

WellPoint Inc. (NYSE: WLP) reported its fourth-quarter income from continuing operations of $524.7 million or $1.33 per share, surpassing the Zacks Consensus Estimate of $1.21. This also compares favorably with the income of $536.0 million or earnings of $1.16 in the year-ago quarter.

WellPoint also posted its income from continuing operations of $2.8 billion or $6.74 per share for fiscal year 2010, surpassing the Zacks Consensus Estimate of $6.60 and the income of $2.9 billion or $6.09 in the fiscal year 2009. The company's earnings were in-line with the management's guidance of above $6.60 earnings per share for the fiscal year 2010.

The improved showing was attributable to higher operating cash flows and the implementation of organizational changes in the health care. The sale of NextRx pharmacy benefit management subsidiaries to Express Scripts (Nasdaq: ESRX) in the fourth quarter of 2009 also contributed a significant return of capital.

WellPoint's income from continuing operations excludes net investment gains of $24.1 million after-tax, or approximately 7 cents per share in the fourth quarter of 2010, and $100.2 million after-tax, or approximately 23 cents per share in fiscal 2010, which was partially offset by an intangible asset impairment charge of $13.7 million after-tax, or 3 cents per share.

The earnings of the fourth quarter of 2009 excluded the after-tax net income of $2.2 billion, or $4.79 per share, resulting from a gain on the sale of the NextRx, partially offset by costs for restructuring activities and intangible asset impairments.

Fiscal year 2009 excluded after-tax net income of approximately $1.8 billion, or $3.79 per share, resulting from the gain on the sale of NextRx, partially offset by net investment losses, intangible asset impairments and costs for restructuring activities.

Including these one-time items, WellPoint reported a net income of $548.8 million or $1.40 per share in the fourth quarter 2010 as opposed to $2.7 billion or $5.95 per share in the prior-year quarter. Net income in 2010 was $2.9 billion or $6.94 per share as against $4.7 billion or $9.88 per share.

Segment Results

Commercial Business: Operating gains in the segment increased 89.6% year over year to $600.7 million in the fourth quarter of 2010 and 27.0% year over year to $3.1 billion in fiscal 2010.

Consumer Business: Operating gains in the segment plummeted 29.5% year over year to $112.0 million in the reported quarter and declined 21.8% year over year to $1.0 billion in fiscal 2010.

Other: Operating gains in this segment experienced an operating loss of $19.6 million in the fourth quarter of 2010, compared with an operating gain of $100.8 million in the fourth quarter of 2009. This was due primarily to the fact that fourth quarter 2009 results included two months of NextRx operations prior to its sale on December 1, 2009.

WellPoint's Others segment also faced an operating loss of $8.8 million in full year 2010 as compared with an operating gain of $469.4 million in full year 2009.

Evaluation of Capital Structure

WellPoint generated operating cash flow of $587.0 million in the fourth quarter of 2010 and $1.4 billion in the fiscal year 2010, which included $1.2 billion of tax payments related to the 2009 sale of NextRx. At the end of December 31, 2010, cash and investments at the parent company totaled approximately $3.3 billion.

As of December 31, 2010, WellPoint had $148.5 million remaining under its share repurchase authorization. During the reported quarter, WellPoint repurchased 17.8 million shares for $1.0 billion and repurchased 76.7 million shares of its stock for approximately $4.4 billion in fiscal 2010, following the sale of NextRx.

During the fourth quarter of 2010, WellPoint witnessed net investment gains of $37.2 million pre-tax, consisting of net realized gains from the sale of securities totaling $47.6 million, partially offset by other-than-temporary impairments totaling $10.4 million.

In the prior year quarter, WellPoint experienced net investment losses of $4.5 million pre-tax, consisting of other-than-temporary impairments of $40.5 million, primarily offset by net realized gains from the sale of securities totaling $36.0 million.

Comparison with Competitors

Rival company Unitedhealth Group, Inc. (NYSE: UNH) reported its fourth quarter results on January 20, 2011 with income from continuing operations of 94 cents per share, better than the Zacks Consensus Estimate of 90 cents. Full year EPS was $4.10, which also surpassed the Zacks Consensus Estimate of $3.99. WellPoint's peers like CIGNA Corporation (NYSE: CI) is scheduled to report its fourth quarter and fiscal year 2010 results on February 3, followed by Aetna Inc. (NYSE: AET) on February 4.

Outlook for Fiscal 2011

WellPoint anticipates a net income of at least $6.30 per share.

Our Recommendation

Though we are pleased with the strong results of WellPoint along with solid capital management, we remain wary of the impact of the health insurance reforms and expect these reforms to increase unemployment and stretch profit margins of WellPoint and its competitors. The resulting downward pressure is likely to overshadow the stock.

WellPoint has a strong cash flow generation, leading market share positions, diversified product portfolio, proven track record of execution, attractive valuation, and consistency that would provide long-term value to its investors. Meanwhile, WellPoint has been increasing its premiums and controlling costs.

Further, WellPoint is well positioned among its peer group and has been strengthening its portfolio through its acquisition strategy, the synergies of which are expected to lead to margin expansion and top-line growth. Moreover, the sale of its in-house pharmacy benefits business to Express Script has strengthened its balance sheet and fueled a major stock repurchase.

Currently, WellPoint carries a Zacks #3 Rank, which translates into a short-term Hold recommendation, indicating no clear directional pressure on the stock over the near term.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5514.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5516

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/ZacksResearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com
SOURCE Zacks Investment Research, Inc.

http://ih.advfn.com/p.php?pid=nmona&article=46193051&symbol=AET

As of September 2010, LegitScript's website indicated that LegitScript had approved over 320 online pharmacy websites as meeting LegitScript's standards, and documented over 48,000 "rogue" online pharmacy websites.

Currently LegitScript's has 99% of Online Pharmacies in it's database not yet "legitimate".

56,964 = pharmacy websites in our database
327 = are legitimate
1,173= are candidates for approval
55,464 = do not meet our standards

$AET LOVES DEMAND MEDIA

ICEQUITY

01/16/11 4:49 AM

Post #4

Re: #3: @ICEQUITY - VIPPS approved pharmacy Aetna (NYSE: AET) is one

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community